Prevalence of hepatitis D virus among HBsAg-positive individuals,2015-2016: Azar cohort study

Ali Asghar Pouri ¹ , Morteza Ghojazadeh ¹ , Babak Baiaz ², Fatemeh Soghra Hamzavi ², Behrouz Pourasghari ², Mohammad Hossein Somi ¹ *

Cited by CrossRef: 7

1- Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. Journal of Hepatology. 2021;74(5):1200 [Crossref]

2- Lazarus J, Al‐Rifai A, Sanai F, Alghamdi A, Sharara A, Saad M, van Selm L, Alqahtani S. Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review. Liver International. 2023;43(S1):116 [Crossref]

3- Isaeva O, Kyuregyan K, Karlsen A, Kuzmin O, Potemkin I, Kichatova V, Asadi Mobarkhan F, Mullin E, Kozhanova T, Manuylov V, Pochtovyy A, Gushchin V, Saryglar A, Ilchenko L, Mikhailov M. Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination. Journal of Viral Hepatitis. 2023;30(3):182 [Crossref]

4- Hama S, Sirwan R, Abubakr M, Ahmed G, Rahim H. Clinical Prevalence of Hepatitis D Virus Among Hepatitis B Patients in Sulaymaniyah Governorate, Northern Iraq. Journal of Viral Hepatitis. 2024;31(11):670 [Crossref]

5- Post Z, Reau N. What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?. Clinics in Liver Disease. 2023;27(4):973 [Crossref]

6- Abdul Majeed N, Zehnder B, Koh C, Heller T, Urban S. Hepatitis delta: Epidemiology to recent advances in therapeutic agents. 2023;78(4):1306 [Crossref]

7- Ghorbani N, Alamdary A, Khanizadeh S, Birjandi M, Ajorloo M. Epidemiological Study of Hepatitis D Virus in HBsAg Positive Patients in Khorramabad City, West of Iran, 2019. Iran J Med Microbiol. 2024;18(1):1 [Crossref]